Absence of leukaemic fusion gene transcripts in preterm infants exposed to diagnostic x rays

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 88, Issue 3, 2003, Pages

  Ravetto, P F ^b   Agarwal, R ^a   Chiswick, M L ^a   D'Souza, S W ^b   Eden, O B ^b   Taylor, G M ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; RNA;

ARTICLE; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; FEMALE; FUSION GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN PERIOD; NUCLEOTIDE SEQUENCE; PREMATURITY; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIODIAGNOSIS; UMBILICAL CORD BLOOD; X RAY;

EID: 0038556699     PISSN: 00039888     EISSN: 13592998     Source Type: Journal    
DOI: 10.1136/fn.88.3.f237     Document Type: Article

References (59)

1. Stewart A, Webb J, Giles D, et al. Malignant disease in childhood and diagnostic irradiation in utero. Lancet 1956;ii:447.
2. Stewart A, Kneale GW. Radiation dose effects in relation to obstetric X-rays and childhood cancers. Lancet 1970;i:1185-8.
3. MacMahon M. Prenatal X-ray exposure and childhood cancer. J Natl Cancer Inst 1962;28:1173-91.
4. Knox EG, Stewart AM, Kneale GW, et al. Prenatal irradiation and childhood cancer. Journal of the Society of Radiological Protection 1987;7:177-89.
5. Bithell JF. Epidemiological studies of children irradiated in utero. In: Baverstock KF, Stather JW, eds. Low dose radiation: biological bases of risk assessment. London: Taylor & Francis, 1989:77-87.
6. National Radiological Protection Board. Estimates of late irradiation risks to the UK population. Chapter 6: Irradiation in utero. Documents of the NRPB 1993;4:105-25.
7. Doll R, WakeFord R. Risk of childhood cancer From Fetal irradiation. Br J Radiol 1997;70:130-9.
8. Rennie JM. Perinatal management at the lower margin of viability. Arch Dis Child Fetal Neonatal Ed 1996;74:F214-F218.
9. Chervenak FA, McCullough LB. The limits of viability. J Perinat Med 1997;25:418-20.
10. Draper ES, Manktelow B, Field DJ, et al. Prediction of survival for preterm births by weight and gestational age: retrospective population based study. BMJ 1999;319:1093-7.
11. Fletcher EWL, Baum JD, Draper G. The risk of diagnostic radiation of the newborn. Br J Radiol 1986;59:165-70.
12. Faulkner K, Barry JL, Smalley P. Radiation dose to neonates on a Special Care Baby Unit. Br J Radiol 1989;62:230-3.
13. Arroe M. The risk of X ray examinations of the lungs in neonates. Acta Paediatr Scand 1991;80:489-93.
14. Chapple CL, Faulkner K, Hunter EW. Energy imparted to neonates during X-ray examinations in a special care baby unit. Br J Radiol 1994;67:366-70.
15. Sutton PM, Arthur RJ, Taylor C, et al. Ionising radiation from diagnostic x rays in very low birtweight babies. Arch Dis Child Fetal Neonatal Ed 1998;78:F227-F229.
16. McParland BJ, Gorka W, Lee R, et al. Radiology in the neonatal intensive care unit: dose reduction and image quality. Br J Radiol 1996;69:927-37.
17. Richardson C, Jasin M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 2000;405:697-700.
18. Raimondi SC. Cytogenetics of acute leukemias. In: Pui C-H, ed. Childhood leukemias. Cambridge: Cambridge University Press, 1999:168-96.
19. Rubnitz JE, Look AT. Molecular genetics of acute lymphoblastic leukemia. In: Pui C-H, ed. Childhood leukemias. Cambridge: Cambridge University Press, 1999:97-218.
20. Downing JR. Molecular genetics of acute myeloid leukemia. In: Pui C-H, ed. Childhood leukemias. Cambridge: Cambridge University Press, 1999:219-54.
21. Ford AM, Bennett CA, Price CM, et al. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci U S A 1998;95:4584-8.
22. Wiemels JL, Ford AM, Van Wering ER, et al. Protracted and variable latency of acute lymphoblastic leukaemia after TEL-AML1 fusion in utero. Blood 1999;94:1057-62.
23. Gale KB, Ford AM, Repp R, et al. Backtracking leukaemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A 1997;94:13950-4.
24. Romana SP, Mauchauffé M, Le Conia M, et al. The t(12;21) of acute lymphoblastic leukaemia results in a tel-AML1 gene fusion. Blood 1995;85:3662-70.
25. Pui CH, Kane JR, Crist WM. Biology and treatment of infant leukaemias. Leukemia 1995;9:762-9.
26. Pui CH, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993;82:343-62.
27. Hart D, Jones DG, Wall BF. Coefficients for estimating effective doses from paediatric X-ray examinations. National Radiological Protection Board Report; NRPB-R279. London: HMSO, 1996.
28. Uphoff CC, MacLeod RA, Denkmann SA, et al. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines. Leukemia 1997;11:441-7.
29. Corral J, Forster A, Thompson S, et al. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci U S A 1993;90:8538-42.
30. Pegoraro L, Matera L, Ritz J, et al. Establishment of a Ph1-positive human cell line (BV173). J Natl Cancer Inst 1983;70:447-53.
31. Cayuela J-M, Baruchel A, Orange C, et al. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia. Blood 1996;88:302-8.
32. Uken FM, Herman-Hatten K, Crotty M-L, et al. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)[q21;q23) chromosomal translocation. Blood 1998;92:810-21.
33. Saglio G, Pane F, Gottardi E, et al. Consistent amounts of acute leukaemia associated P190 BCR/ABL transcripts are expressed by chronic myelogenous leukaemia patients at diagnosis. Blood 1996;87:1075-80.
34. Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukaemia phenotype. Blood 1996;88:2375-84.
35. Wall BF, Hart D. Revised radiation doses for typical X-ray examinations. Report of a recent review of doses to patients from medical X-ray examination in the UK by NRPB. Br J Radiol 1997;70:437-9.
36. Huda W, Chamberlain CC, Rosenbaum AE, et al. Radiation doses to infants and adults undergoing head CT examinations. Med Phys 2001;28:393-9.
37. Deininger MWN, Bose S, Gora-Tybor J, et al. Selective induction of leukaemia-associated fusion genes by high-dose ionizing radiation. Cancer Res 1998;58:421-5.
38. Spencer A, Granter N. Leukemia patient-derived lymphoblastoid cell lines exhibit increased induction of leukemia-associated transcripts following high-dose irradiation. Exp Hematol 1999;27:1397-401.
39. Goodhead DT. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int J Radiat Biol 1994;65:7-17.
40. Kadhim MA, Marsden SJ, Goodhead DT, et al. Long term genomic instabiility in human lymphocytes induced by single-particle irradiation. Radiat Res 2001;155:122-6.
41. Nikiforova MN, Stringer JR, Blough R, et al. Proximity of chromosomal loci that participate in radiation-induced rearrangement in human cells. Science 2000;290:138-41.
42. Kozubek S, Lukášová E, Rýznar L, et al. Distribution of abl and bcr genes in cell nuclei of normal and irradiated lymphocytes. Blood 1997;89:4537-45.
43. Wiemels JL, Cazzaniga G, Daniotti M, et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 1999;354:1499-503.
44. Biernaux C, Loos M, Sels A, et al. Detection of major bcr-abl gene expression at a very low levels in blood cell of some healthy individuals. Blood 1995;86:3118-22.
45. Bose S, Deininger M, Gora-Tybor J, et al. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood 1998;92:3362-7.
46. Eguchi-Ishimae M, Eguchi M, Ishii E, et al. Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals. Blood 2001;97:737-43.
47. Mori H, Xiao Z, Ford AM, et al. TEL-AML1 and AML1-ETO fusion sequences in normal newborn cord bloods. Blood 2000;96:88a.
48. Trka J, Zuna J, Zavacka-Polouckova A, et al. Evidence for the presence of t(12;21) in cord blood samples of healthy newborns. Blood 2000;96:694a.
49. Little JB. Radiation-induced genomic instability. Int J Radiat Biol 1998;74:663-71.
50. Trka J, Zuna J, Hrušák O, et al. No evidence for MLL/AF4 expression in normal cord blood samples. Blood 1999;93:1106-7.
51. Kim-Rouille M-H, MacGregor A, Wiedemann LM, et al. MLL-AF4 gene fusions in normal newborns. Blood 1999;93:1107-8.
52. Schnittger S, Wormann B, Hiddermann W, et al. Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood 1998;92:1728-34.
53. Goodhead DT. Track structure considerations in low dose and low dose rate effects of ionizing radiation. Advances in Radiation Biology 1992;16:7-44.
54. Waugh AP, Beare DM, Arlett CF, et al. Comparative human cellular radiosensitivity: IV. The increased sensitivity of human neonatal cord blood lymphocytes to gamma-irradiation compared with lymphocytes from children and adults. Int J Radiat Biol 1991;59:767-76.
55. Linhart Y, Bashiri A, Maymon E, et al. Congenital anomalies are an independent risk factor for neonatal morbidity and perinatal mortality in preterm birth. Eur J Obstet Gynaecol Reprod Biol 2000;90:43-9.
56. Mann JR, Dodd HE, Draper GJ, et al. Congenital abnormalities in children with cancer and their relatives: results from a case-control study (IRESCC). Br J Cancer 1993;68:357-63.
57. Stiller CA, Allen MB, Eatock EM. Childhood cancer in Britain: the national registry of childhood tumours and incidence rates 1978-1987. Eur J Cancer 1995;31A:2028-34.
58. Yotdna P, Garcia F, Peuchmaur M, et al. Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia. J Clin Invest 1998;102:455-62.
59. Yun C, Senju S, Fujita H, et al. Augmentation of immune reponses by altered peptide ligands of the antigenic peptide in a human CD4+ T-cell clone reacting to TEL/AML1 fusion protein. Tissue Antigens 1999;54:153-61.